Trials / Completed
CompletedNCT04377035
The Role of Ultrasound in COVID-19
The ECHOVID-19 Study - A Prospective Cohort Study Investigating the Acute Effect of COVID-19 on the Heart and Lung by Ultrasound
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 305 (actual)
- Sponsor
- University Hospital, Gentofte, Copenhagen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The study is a prospective clinical cohort study of consecutive patients hospitalized at all hospitals of greater Copenhagen with a laboratory confirmed diagnosis of COVID-19. The investigators aim to examine if echocardiography - both conventional and advanced - can be used to predict which patients will develop acute respiratory distress syndrome (ARDS) or other short-term acute complications, especially focusing on cardiovascular outcomes. In addition, using a novel technique of lung ultrasound (LUS), The investigators aim to analyze specific LUS-findings, and associate them with short-term prognosis and development of ARDS and long-term cardiovascular morbidity and mortality. In all patients included, The investigators aim to examine long-term complications at timepoints: 2, 5 and 10 years of follow-up and examine if echocardiography - alone and in combination with biomarkers - can be used to detect early signs of cardiac complications and predict long-term risk of cardiovascular morbidity and mortality following COVID-19 infection
Conditions
Timeline
- Start date
- 2020-03-31
- Primary completion
- 2021-03-01
- Completion
- 2021-03-01
- First posted
- 2020-05-06
- Last updated
- 2023-06-26
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04377035. Inclusion in this directory is not an endorsement.